Clinical trial
Z 31411 - The Effect of Xpert MTB/RIF on Patient Health Outcomes and Empirical TB Treatment Among Persons Living With HIV/AIDS: A Parallel-Group Prospective Cohort Study Under Real-World Conditions in Lusaka, Zambia
NCT02729532 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Z 31411 - The Effect of Xpert MTB/RIF on Patient Health Outcomes and Empirical TB Treatment Among Persons Living With HIV/AIDS: A Parallel-Group Prospective Cohort Study Under Real-World Conditions in Lusaka, Zambia
- Lead sponsor
- University of North Carolina, Chapel Hill
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 22, 2016
- Completion date
- February 9, 2018
- Enrollment
- 776 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.